Cannabis as Painkiller
Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29–30 of Deutsches Ärzteblatt International.
Cannabis medications can be used in patients whose symptoms are not adequately alleviated by conventional treatment. The indications are muscle spasms, nausea and vomiting as a result of chemotherapy, loss of appetite in HIV/Aids, and neuropathic pain.
The clinical effect of the various cannabis-based medications rests primarily on activation of endogenous cannabinoid receptors. Consumption of therapeutic amounts by adults does not lead to irreversible cognitive impairment. The risk is much greater, however, in children and adolescents (particularly before puberty), even at therapeutic doses.
Over 100 controlled trials of the effects of cannabinoids in various indications have been carried out since 1975. The positive results have led to official licensing of cannabis-based medications in many countries. In Germany, a cannabis extract was approved in 2011 for treatment of spasticity in multiple sclerosis. In June 2012 the Federal Joint Committee (the highest decision-making body for the joint self-government of physicians, dentists, hospitals and health insurance funds in Germany) pronounced that the cannabis extract showed a slight additional benefit for this indication and granted a temporary license until 2015.

Cannabis as Painkiller

Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29–30 of Deutsches Ärzteblatt International.

Cannabis medications can be used in patients whose symptoms are not adequately alleviated by conventional treatment. The indications are muscle spasms, nausea and vomiting as a result of chemotherapy, loss of appetite in HIV/Aids, and neuropathic pain.

The clinical effect of the various cannabis-based medications rests primarily on activation of endogenous cannabinoid receptors. Consumption of therapeutic amounts by adults does not lead to irreversible cognitive impairment. The risk is much greater, however, in children and adolescents (particularly before puberty), even at therapeutic doses.

Over 100 controlled trials of the effects of cannabinoids in various indications have been carried out since 1975. The positive results have led to official licensing of cannabis-based medications in many countries. In Germany, a cannabis extract was approved in 2011 for treatment of spasticity in multiple sclerosis. In June 2012 the Federal Joint Committee (the highest decision-making body for the joint self-government of physicians, dentists, hospitals and health insurance funds in Germany) pronounced that the cannabis extract showed a slight additional benefit for this indication and granted a temporary license until 2015.

(Source: neurosciencestuff)

Posted on August 8th at 4:08 PM
Has a total of: 165 Notes

  1. verygoodurl reblogged this from yawnrape
  2. yawnrape reblogged this from fuckyeahstonerkids
  3. shakethatbook reblogged this from neurosciencestuff
  4. nic0tinequeen reblogged this from fuckyeahstonerkids and added:
    (via imgTumble)
  5. amberlynnschwag reblogged this from octanedrug
  6. haileybaby420 reblogged this from fuckyeahstonerkids
  7. fuckthecrucifix reblogged this from stonerproblemss
  8. paz-e-4mor reblogged this from iliketupac
  9. eazy-er-said-than-dunnn reblogged this from stonerproblemss
  10. iliketupac reblogged this from a-gingers-perspective
  11. nikkilove reblogged this from stonerproblemss
  12. holololy reblogged this from kingcatsby
  13. wutthafuck reblogged this from fuckyeahstonerkids
  14. worldwidebubu reblogged this from fuckyeahstonerkids
  15. alexandria-marie-jackson reblogged this from fuckyeahstonerkids
  16. wordofthesummit reblogged this from fuckyeahstonerkids
  17. thebrideofbeetlegeuse reblogged this from stonerproblemss
  18. anteangeolai reblogged this from neurosciencestuff
  19. myphollection reblogged this from naomeapetecepensarmuito
  20. kingcatsby reblogged this from stonerproblemss
  21. truckin-deadhead reblogged this from fuckyeahstonerkids
  22. sliverdemon reblogged this from neurosciencestuff
  23. clicher reblogged this from stonerproblemss
  24. lfleecs reblogged this from saturnsuns
  25. mikaylaaleighh reblogged this from fuckyeahstonerkids
  26. gates0fdelirium reblogged this from stonerproblemss
  27. itzstew reblogged this from stonerproblemss
  28. sequinedrose reblogged this from neurosciencestuff
  29. underaswiftsunrise reblogged this from fuckyeahstonerkids
+